Research & Publications

Simanjuntak, Destrina Grace and Tjandrawinata, Raymond R., M&A of Generic Pharmaceutical Companies Increases Productivity (Oct 20, 2011). Available at SSRN: http://ssrn.com/abstract=1946761

Dirjomuljono M, Tjandrawinata RR. Clinical trials involving Phyllanthus species In : Kuttan R, Harikumar KB, editors. Phyllanthus Species. Scientific evaluation and medicinal applications. Florida: CRC Press, Taylor & Francis Group, 2012.p.289–313.

Asep Aripin, Rinaldi Salea, Bambang Veriansyah, dan Raymond R Tjandrawinata. Ekstraksi Minyak Biji Teh dengan Karbon Dioksida (CO2) pada Kondisi Superkritis. Jurnal Bahan Alam Indonesia; ISSN 1412-2855 8 (3), September 2012.

Simanjuntak, Destrina Grace and Tjandrawinata, Raymond R., Sales Revenue Determinants for Generic Pharmaceutical Companies (Sept 28, 2011). Available at SSRN: http://ssrn.com/abstract=1933687

Hiendrawan S., Veriansyah B., Tjandrawinata R. Micronization of DLBS 2411 using Aerosol Solvent Extraction System. Supergreen 2011-The 7th International Conference on Supercritical Fluids, Beijing, China; 08/2011.

Arifin, P.F., Tjandrawinata, R.R and Clarissa A. New Concept in the treatment of Premenstrual syndrome using bioactive fraction DLBS 1442. Medicinus 24(3):21-24, 2011.

Simanjuntak, Destrina Grace and Tjandrawinata, Raymond R., Factors Influencing Sales Revenue in the Multinational Pharmaceutical Companies (July 28, 2011). Available at SSRN: http://ssrn.com/abstract=1898071

Simanjuntak, Destrina Grace and Tjandrawinata, Raymond R. (2011): A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia (June 2011). Working paper available at http://mpra.ub.uni-muenchen.de/31628

Tjandrawinata R.R., Nofiarny D., Susanto L.W., Hendri P., Clarissa A. Symptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpa. Int. J. Gen. Med. 2011;4:465-76. Epub 2011 Jun 16.

Simanjuntak, Destrina Grace and Tjandrawinata, Raymond R., Impact of Profitability, R&D Intensity, and Cash Flow on R&D Expenditure in Pharmaceutical Companies (May 5, 2011). Available at SSRN: http://ssrn.com/abstract=1824267

Sajuthi, D., Suhartono, M.T., Tjandrawinata, R.R. Studi Keamanan pemberian Fraksi protein Bioaktif DLBS 1033 Pada monyer Ekor Panjang (macaca fascicularis). Medicinus 24(2):15-21, 2011.

Tjandrawinata, R.R. The Influence of Oxidative stress on vaskular gene expression. Medicinus 24(2): 6-11, 2011.

Tandrasasmita O.M., Wulan D.D., Nailufar F., Sinambela J., Tjandrawinata R.R. Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression. Int. J. Gen. Med. 2011;4:345-57. Epub 2011 May 3.

Tandrasasmita, O., Diah D., Sinambela, J. and Tjandrawinata, R.R. DLBS3233 increases glucose uptake by mediating upregulation of PPARγ and GLUT4 expression. Biomedicine and Preventive Nutrition 1(2): 71-78, 2011 (April–June 2011).

Trisina, J., Sunardi, F., Suhartono, M.T., Tjandrawinata, R.R. DLBS1033, a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activities. Journal of Biomedicine and Biotechnology. J Biomed Biotechnol. 2011:519652. Epub 2011 Mar 3.

Kurnia, F. and Tjandrawinata, R.R. Bioactive protein fraction DLBS1033 exerts its positive pleiotropic effects in the vascular cells via down regulation of gene expression. Medicinus 24(1): 18-24, 2011.

Nailufar, F. and Tjandrawinata, R.R. Effect of DLBS3233, an insulin sensitizer, on fructose-induced insulin resistance rats. Medicinus 24(1): 13-17 2011.

Susalit S., Agus, N, Effendi I., Tjandrawinata R.R., Nofiarny D., Perrinjaquet-Moccetti T., Verbruggen M. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril. Phytomedicine. 18(4):251-8, 2011.

Chun-Won Lee, Soo-Jung Kim, Yong-Suk Youn, Edward Widjojokusumo, Young-Ho Lee, Jaehoon Kim, Youn-Woo Lee and Raymond R. Tjandrawinata. Preparation of bitter taste masked cetirizine dihydrochloride/β-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. The Journal of Supercritical Fluids 55(1): 348-357, 2010.

Arifin, P.F. and Tjandrawinata R.R. Proliferation inhibition by DLBS 1425 On Various Cancer cells. Medicinus 23(4): 16-19, 2010.